<Anchor>
Another interesting thing in Trump's news is the cure.
The health authorities have not yet granted permission, so they have announced that they have been injected with drugs that have not been confirmed to be effective or safe, but there are many stories about why and why.
Medical reporter Cho Dong-chan, a specialist, pointed this out.
<Reporter> The
primary drug chosen by Trump's doctor is a complex antibody drug developed by Regeneron in the United States.
It is a cocktail-like mixture of two types of antibodies each extracted from the plasma of a human-specific rat and a patient recovering from COVID-19.
One type of antibody treatment is made with two types of antibodies because there are many ``virus avoidance'' symptoms in which the Corona 19 virus does not work even if only a part of the gene is changed.
It was selected as an'experimental treatment' method because it was undergoing phase 3 clinical trials, and Trump was administered a high dose, which was more effective in clinical practice.
The White House has since given a licensed injection of remdesivir and said it will be administered for five days.
It is unusual for the President of the United States to first select a drug that has not yet been approved as a treatment drug before knowing the effectiveness of a licensed drug.
[Marc Jarret/Professor at Northwell Health Medical School, USA: Remdesivir may not be effective enough, but it may be helpful, and new complex antibody drugs are available (may be effective)]
The White House may have secured reliable, undisclosed data for a new complex antibody drug, or it may have prepared for the possibility that President Trump's prognosis, which is classified as a high-risk group such as old age, obesity, and heart disease, will not be light because it relies solely on remdesivir.
The malaria treatment, which President Trump praised, was canceled by the FDA in June for emergency use and was not used in this treatment.
(Video coverage: Lee Jae-young, video editing: Kim Ho-jin)